Naturgy Builds Fourth Biomethane Plant in Spain
By Giulia Petroni
Naturgy is building a biomethane plant treating agro-industrial waste in the Spanish province of Lleida for a total investment of 18 million euros ($19.7 million).
The energy company said Tuesday that the facility, scheduled to be commissioned in 2025, will treat 140,000 metric tons a year of agro-industrial and livestock waste from the area, generating 60 gigawatt hours of renewable gas a year.
That is equivalent to the annual consumption of 16,000 households, according to Naturgy, and is set to prevent the emission of 15,000 tons of carbon dioxide per year.
The biomethane generated at the plant will be injected directly into the network of the area's gas distrubutor Nedgia.
Naturgy currently operates three other plants for the production of biomethane in Spain.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
June 20, 2023 06:31 ET (10:31 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track